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Editorial on the Research Topic
Freeze-Drying and Process Analytical Technology for Pharmaceuticals
This Research Topic was focused on the freeze-drying process, a key step in the manufacturing
of the pharmaceutical products due to the higher stability of solid drugs at solid state than in
liquid solution, and to the fact that it allows removing the liquid from a product operating at
low temperature. In 2016, 50% of the new drugs approved by the FDA were biopharmaceuticals,
and about 50% of the approved biopharmaceutical drugs in the FDA and EMA lists requires
freeze-drying in the manufacturing process.
Although the freeze-drying process is quite often regarded as a “soft” drying process, due to
the low operating temperatures, the operating conditions have to be carefully selected aiming (i)
to preserve the critical quality attributes of the product, and (ii) to minimize the duration and,
thus, the cost of the process. In this framework it is particularly important to focus on product
temperature, as it has to be maintained below a threshold value, that is a characteristic of the
product being processed, in order to avoid the denaturation of the drug and/or the collapse of the
dried cake (in case of amorphous products) or its melting (in case of crystalline products). Besides,
it is necessary to detect in-line the ending point of the drying sage. Finally, it could be useful to
estimate the values of the parameters of the mathematical model used to simulate, and optimize,
in silico the process (the heat transfer coefficient between the shelf and the product in the vial, and
the mass transfer resistance of the dried product to vapor flow).
Since the issue in 2004, the “Guideline for Industry PAT” motivated the researchers and
the practitioners in the pharmaceutical field to develop systems, named “Process Analytical
Technology” (PAT), for monitoring (and controlling) the manufacturing process. By this way the
quality of the product is no longer tested at the end of the process itself, but it is evaluated in-line
and, if necessary, the operating conditions are modified in order to get the desired result.
Despite the huge effort of many research groups to propose new hardware and software tools
for monitoring the process, thermocouples remain widely used, and new hardware solutions have
been recently proposed.
The use of thermocouples or temperature sensors as a true PAT tool has limitations,
as any tool that is invasive to the product is not necessarily representative of the process.
In addition, the information obtained using temperature sensors directly in the product to
determine product temperature profile, and the endpoint of primary drying, depends greatly
on placement. Placement can be somewhat controlled at small scale but the placement
of thermocouples in the product at large scale is very challenging, due to scale and
loading systems etc. There has been a variety of temperature sensors proposed in the
literature, some positioned directly into the product, and some external to the product on
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the outside of the vial. To reduce the challenge at large scale,
wireless sensors have been proposed. Apart from temperature
sensors, the use of PAT technology at large scale and during
commercial manufacturing has not been applied as fast as
anticipated. One of the solutions to the impact of the temperature
sensor positioned directly in the product would be to attempt
to control ice nucleation and reduce the degree of supercooling,
thereby making representative what would not have been with a
temperature sensor in place.
Jiang et al. proposed a multi-point wireless system to track
product temperature at several axial positions, allowing also the
detection of the ending point of the process, and the rapid
identification of the sublimation rate and of the heat transfer
coefficient. Demichela et al. focused on the problem of the effect
of incorrect thermocouples placement, as in most cases the
system is assumed to track the dynamics at the vial bottom, in
central position, and, due to incorrect placement of the sensor,
erroneous conclusions may be driven. Therefore, beside the
instrument error, this additional source of uncertainty has to be
accounted for.
Monitoring of product temperature in a freeze-drying process
is required as it is mandatory to properly select the operating
conditions, namely the temperature of the heating shelf and
the pressure in the drying chamber, in such a way that the
temperature remains below a limit value that is a characteristic
of the product being processed. The collapse temperature and
the glass transition temperature are the two characteristics that
guide the development of the process. Differential Scanning
Calorimetry (DSC) and Freeze-Drying Microscopy (FDM) are
the two techniques traditionally used to this purpose. The
optical fibre system unit may be used as an alternative tool to
detect both glass transition and collapse temperature, as well as
crystallization events (Horn and Friess). It has to be remarked
that this system tracks the process in one of the vials undergoing
the freeze-drying process in the real equipment and, thus, more
representative data are expected with respect to DSC and FDM.
Besides, there is a strong interest in monitoring what is
occurring during the freeze-drying process and, in particular,
microstructure formation, e.g., the ice crystal formation and
growth in the freezing stage, as this is a key point to be
considered due to its effect on the successive drying stage.
Up to now most of the research has been focused on the ice
sublimation stage, and the in-situ X-ray computed tomography
proposed by Nakagawa et al. may be effective to assess the
effect of the freezing conditions (e.g., annealing on product
structure). In conclusion, it is necessary to point out that the
application of PAT to lyophilization at large scale, for in-line
monitoring and control, is still far from being the standard
approach in the manufacturing of pharmaceutical products.
In fact, PAT is nowadays considered mainly a development
and scale up tool, used at lab-scale for process design and
optimization. At industrial scale, PAT is looked as a tool
for process monitoring, and not for control purposes. This
is due to the fact that a commercial manufacturing entity
prefer a known cycle time, well designed, to allow planning of
manufacturing schedules, and the design of a freeze-drying cycle
using well defined models, heat transfer, mass transfer, product
characteristics, robust and fit to scale and load is preferred at
lab scale. It is therefore necessary to strengthen the research
in this field, focusing on the application at industrial scale
of these devices, and pointing out the advantages, in terms
of final product characteristics, that can be achieved by this
way.
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